OSTEOGENIC SARCOMA - IMMUNOLOGICAL PARAMETERS BEFORE AND DURING IMMUNOTHERAPY WITH TUMOR-SPECIFIC TRANSFER-FACTOR

被引：97

作者：

LEVIN, AS

BYERS, VS

FUDENBERG, HH

WYBRAN, J

HACKETT, AJ

JOHNSTON, JO

SPITLER, LE

机构：

[1] UNIV CALIF, SCH MED, SAN FRANCISCO, CA 94143 USA

[2] UNIV CALIF, BERKELEY, CA 94720 USA

[3] WESTERN LABS, OAKLAND, CA 94609 USA

[4] KAISER FDN HOSP, OAKLAND, CA 94611 USA

来源：

关键词：

D O I：

10.1172/JCI107955

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：487 / 499

页数：13

共 29 条

[1] TUMOR-SPECIFIC CELL-MEDIATED-IMMUNITY IN HOUSEHOLD CONTACTS OF CANCER-PATIENTS
BYERS, VS
LEVIN, AS
HACKETT, AJ
FUDENBERG, HH
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1975, 55 (03) : 500 - 513
[2] FUTURE OF TUMOR IMMUNOLOGY
CINADER, B
[J]. MEDICAL CLINICS OF NORTH AMERICA, 1972, 56 (03) : 801 - +
[3] Fisher B, 1971, Adv Surg, V5, P189
[4] JAFFE N, 1972, CANCER-AM CANCER SOC, V30, P1627, DOI 10.1002/1097-0142(197212)30:6<1627::AID-CNCR2820300631>3.0.CO
[5] 2-H
[6] JOHNSTON JO, 1972, PATHOLOGY BONE TUMOR, P1
[7] Lawrence H S, 1969, Adv Immunol, V11, P195, DOI 10.1016/S0065-2776(08)60480-0
[8] TRANSFER IN HUMANS OF DELAYED SKIN SENSITIVITY TO STREPTOCOCCAL-M SUBSTANCE AND TO TUBERCULIN WITH DISRUPTED LEUCOCYTES
LAWRENCE, HS
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (02) : 219 - 230
[9] LAWRENCE HS, 1969, MEDIATORS CELLULAR I
[10] LEVIN A S, 1972, Clinical Research, V20, P568